Owen Hughes - Net Worth and Insider Trading

Owen Hughes Net Worth

The estimated net worth of Owen Hughes is at least $8 Million dollars as of 2024-04-19. Owen Hughes is the President and CEO of Cullinan Therapeutics Inc and owns about 506,226 shares of Cullinan Therapeutics Inc (CGEM) stock worth over $8 Million. Owen Hughes is the Director of Radius Health Inc and owns about 10,650 shares of Radius Health Inc (RDUS) stock worth over $345,806. Owen Hughes is also the Exec Chairman and Interim CEO of XOMA Corp and owns about 2,000 shares of XOMA Corp (XOMA) stock worth over $50,960. Besides these, Owen Hughes also holds Translate Bio Inc (TBIO) . Details can be seen in Owen Hughes's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Owen Hughes has not made any transactions after 2023-10-02 and currently still holds the listed stock(s).

Transaction Summary of Owen Hughes

To

Owen Hughes Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Owen Hughes owns 7 companies in total, including Translate Bio Inc (TBIO) , Radius Health Inc (RDUS) , and Cullinan Oncology Inc (CGEM) among others .

Click here to see the complete history of Owen Hughes’s form 4 insider trades.

Insider Ownership Summary of Owen Hughes

Ticker Comapny Transaction Date Type of Owner
TBIO Translate Bio Inc 2021-09-14 director
RDUS Radius Health Inc 2022-08-15 director
CGEM Cullinan Oncology Inc 2021-01-12 director & President and CEO
PRDS Pardes Biosciences Inc 2021-02-16 director
XOMAO.PFD XOMA Corp 2023-01-03 director & Interim CEO
IKNA Ikena Oncology Inc 2022-12-14 director
XOMA XOMA Corp 2023-10-02 director & Interim CEO

Owen Hughes Latest Holdings Summary

Owen Hughes currently owns a total of 4 stocks. Among these stocks, Owen Hughes owns 506,226 shares of Cullinan Therapeutics Inc (CGEM) as of January 12, 2021, with a value of $8 Million and a weighting of 95.23%. Owen Hughes owns 10,650 shares of Radius Health Inc (RDUS) as of February 26, 2020, with a value of $345,806 and a weighting of 4.15%. Owen Hughes also owns 2,000 shares of XOMA Corp (XOMA) as of October 2, 2023, with a value of $50,960 and a weighting of 0.61%. The other 1 stocks Translate Bio Inc (TBIO) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Owen Hughes

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CGEM Cullinan Therapeutics Inc 2021-01-12 506,226 15.66 7,927,499
RDUS Radius Health Inc 2020-02-26 10,650 32.47 345,806
XOMA XOMA Corp 2023-10-02 2,000 25.48 50,960
TBIO Translate Bio Inc 2021-09-14 0 37.36 0

Holding Weightings of Owen Hughes


Owen Hughes Form 4 Trading Tracker

According to the SEC Form 4 filings, Owen Hughes has made a total of 1 transactions in Cullinan Therapeutics Inc (CGEM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cullinan Therapeutics Inc is the acquisition of 2,500 shares on January 12, 2021, which cost Owen Hughes around $52,500.

According to the SEC Form 4 filings, Owen Hughes has made a total of 1 transactions in Radius Health Inc (RDUS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Radius Health Inc is the sale of 2,750 shares on February 26, 2020, which brought Owen Hughes around $49,363.

According to the SEC Form 4 filings, Owen Hughes has made a total of 3 transactions in XOMA Corp (XOMA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in XOMA Corp is the acquisition of 1,000 shares on October 2, 2023, which cost Owen Hughes around $13,830.

More details on Owen Hughes's insider transactions can be found in the Insider Trading History of Owen Hughes table.

Insider Trading History of Owen Hughes

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Owen Hughes Trading Performance

GuruFocus tracks the stock performance after each of Owen Hughes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Owen Hughes is 16.33%. GuruFocus also compares Owen Hughes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Owen Hughes within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Owen Hughes's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Owen Hughes

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 24.16 16.33 34.27 -53.67 -39.42 -29
Relative Return to S&P 500(%) 22.49 7.02 16.95 -78.01 -41.79 -36.97

Owen Hughes Ownership Network

Ownership Network List of Owen Hughes

No Data

Ownership Network Relation of Owen Hughes


Owen Hughes Owned Company Details

What does Translate Bio Inc do?

Who are the key executives at Translate Bio Inc?

Owen Hughes is the director of Translate Bio Inc. Other key executives at Translate Bio Inc include director & Chief Executive Officer & other: President Renaud Ronald C Jr , Chief Operating Officer & CLO & other: Secretary Paul D. Burgess , and 10 percent owner Shire Human Genetic Therapies, Inc. .

Translate Bio Inc (TBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Translate Bio Inc (TBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Translate Bio Inc (TBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Translate Bio Inc (TBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Translate Bio Inc Insider Transactions

No Available Data

Owen Hughes Mailing Address

Above is the net worth, insider trading, and ownership report for Owen Hughes. You might contact Owen Hughes via mailing address: C/o Radius Health, Inc., 201 Broadway, 6th Floor, Boston Ma 02139.

Discussions on Owen Hughes

No discussions yet.